Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
545
-
Total 13F shares, excl. options
-
177M
-
Shares change
-
-8.14M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
-$694M
-
Put/Call ratio
-
0.63
-
Number of buys
-
272
-
Number of sells
-
-278
-
Price
-
$70.29
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q3 2024
687 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q3 2024.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 545 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
of 192M outstanding shares and own 92.2% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (22.6M shares), VANGUARD GROUP INC (19.3M shares), PRIMECAP MANAGEMENT CO/CA/ (18.9M shares), Dodge & Cox (13.9M shares), Capital Research Global Investors (10.5M shares), VIKING GLOBAL INVESTORS LP (9.75M shares), STATE STREET CORP (8.82M shares), AMERIPRISE FINANCIAL INC (4.28M shares), Elliott Investment Management L.P. (3.5M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.26M shares).
This table shows the top 545 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.